Healthcare Sector

Members of Parliament invested in the Healthcare Sector

155 investments

71 companies

Investors

Filed	Name	Company	Pur. £	Cur. £	P/L %	MPV*
Feb '17	Lord Arbuthnot of Edrom	Neuro-bio / NMS:NBIX	£43.24	£151.96	251.43%	£246,003.70
Apr '16	Baroness Greenfield	Neuro-bio / NMS:NBIX	£46.13	£151.96	229.42%	£230,591.81
Apr '24	Lord Balfe	Astrazeneca / LSE:AZN.L	£12,024.00	£13,694.00	13.89%	£79,722.22
Dec '16	Lord Burns	Astrazeneca / LSE:AZN.L	£4,116.00	£13,694.00	232.70%	£232,891.16
May '20	Lord Deighton	Astrazeneca / LSE:AZN.L	£8,361.00	£11,236.00	34.39%	£94,070.09**
Mar '14	Viscount Eccles	Astrazeneca / LSE:AZN.L	£3,876.50	£13,694.00	253.26%	£247,279.76
Feb '21	Lord Etherton	Astrazeneca / LSE:AZN.L	£7,422.00	£13,694.00	84.51%	£129,153.87
May '23	Lord Fink	Astrazeneca / LSE:AZN.L	£11,774.00	£13,694.00	16.31%	£81,414.98
Sep '16	Lord Gadhia	Astrazeneca / LSE:AZN.L	£5,099.00	£10,024.00	96.59%	£137,611.30**
Apr '12	Lord Glendonbrook	Astrazeneca / LSE:AZN.L	£2,666.50	£13,694.00	413.56%	£359,489.97
May '24	Lord Goldsmith	Astrazeneca / LSE:AZN.L	£12,156.00	£13,694.00	12.65%	£78,856.53
May '18	Lord Grabiner	Astrazeneca / LSE:AZN.L	£5,417.00	£13,694.00	152.80%	£176,957.73
May '23	Lord Leitch	Astrazeneca / LSE:AZN.L	£11,820.00	£12,340.00	4.40%	£73,079.53**
May '23	Lord Londesborough	Astrazeneca / LSE:AZN.L	£11,924.00	£13,694.00	14.84%	£80,390.81
Nov '23	Lord Mance	Astrazeneca / LSE:AZN.L	£10,230.00	£13,694.00	33.86%	£93,702.83
Jun '21	Lord Morse	Astrazeneca / LSE:AZN.L	£8,005.00	£13,694.00	71.07%	£119,747.66
Apr '10	Baroness Noakes	Astrazeneca / LSE:AZN.L	£2,938.00	£13,694.00	366.10%	£326,269.57
Dec '23	Lord Browne of Madingley	Allurion / NYQ:ALUR	£3.31	£1.59	-51.96%	£33,625.38
Dec '16	Lord Burns	Glaxosmithkline / NYQ:GSK	£37.39	£48.97	30.97%	£91,679.60
Mar '14	Baroness Eccles of Moulton	Glaxosmithkline / NYQ:GSK	£53.43	£48.97	-8.35%	£64,156.84
Apr '21	Lord Farmer	Glaxosmithkline / NYQ:GSK	£36.65	£40.88	11.54%	£78,079.12**
Jan '20	Lord Gadhia	Glaxosmithkline / NYQ:GSK	£46.50	£40.95	-11.94%	£61,645.16**
May '11	Lord Glendonbrook	Glaxosmithkline / NYQ:GSK	£42.78	£48.97	14.47%	£80,128.57
Apr '10	Lord Levene of Portsoken	Glaxosmithkline / NYQ:GSK	£39.38	£48.97	24.35%	£87,046.72
Mar '17	Lord Lloyd-Webber	Glaxosmithkline / NYQ:GSK	£42.31	£48.97	15.74%	£81,018.67
Apr '10	Baroness Noakes	Glaxosmithkline / NYQ:GSK	£39.49	£48.97	24.01%	£86,804.25
Jan '13	Lord Sassoon	Glaxosmithkline / NYQ:GSK	£44.75	£48.97	9.43%	£76,601.12
Oct '20	Lord Taverne	Glaxosmithkline / NYQ:GSK	£37.57	£40.95	9.00%	£76,297.58**
May '24	Lord Balfe	Glaxosmithkline / NYQ:GSK	£44.02	£48.97	11.24%	£77,871.42
May '25	Lord Hayward	Glaxosmithkline / NYQ:GSK	£37.37	£48.97	31.04%	£91,728.66
Aug '14	Lord Carter of Coles	Johnson & Johnson / NYQ:JNJ	£100.16	£161.55	61.29%	£112,904.35**
Apr '22	Lord Cromwell	Johnson & Johnson / NYQ:JNJ	£179.90	£154.37	-14.19%	£60,066.15**
May '23	Lord Fink	Johnson & Johnson / NYQ:JNJ	£165.03	£205.33	24.42%	£87,093.86
Jul '16	Lord Lloyd-Webber	Johnson & Johnson / NYQ:JNJ	£122.64	£205.33	67.42%	£117,197.49
Jan '13	Lord Sassoon	Johnson & Johnson / NYQ:JNJ	£72.69	£205.33	182.47%	£197,731.46
Aug '17	Lord Sterling of Plaistow	Johnson & Johnson / NYQ:JNJ	£133.45	£157.98	18.38%	£82,866.99**
Feb '11	Lord Wasserman	Johnson & Johnson / NYQ:JNJ	£60.93	£205.33	236.99%	£235,895.29
Mar '25	Lord Fink	Johnson & Johnson / NYQ:JNJ	£161.72	£205.33	26.97%	£88,876.45
Aug '18	Lord Carter of Coles	Danaher / NYQ:DHR	£90.94	£223.01	145.23%	£171,659.87**
Apr '22	Lord Cromwell	Danaher / NYQ:DHR	£245.55	£201.40	-17.98%	£57,414.25**
Jul '16	Lord Glendonbrook	Danaher / NYQ:DHR	£72.15	£228.46	216.63%	£221,639.04
Apr '22	Lord Grabiner	Danaher / NYQ:DHR	£248.88	£228.46	-8.21%	£64,255.90
Aug '17	Lord Sterling of Plaistow	Danaher / NYQ:DHR	£71.88	£212.78	196.02%	£207,216.44**
Jul '18	Lord Carter of Coles	Essilor International / VIE:EI.VI	£126.10	£316.70	151.15%	£175,804.93**
Aug '18	Lord Carter of Coles	Unitedhealth Group / NYQ:UNH	£253.22	£339.71	34.16%	£93,909.25
Jan '23	Lord Goldsmith	Unitedhealth Group / NYQ:UNH	£490.06	£339.71	-30.68%	£48,524.06
Nov '23	Lord Mance	Unitedhealth Group / NYQ:UNH	£537.83	£339.71	-36.84%	£44,214.15
Jan '18	Lord Sterling of Plaistow	Unitedhealth Group / NYQ:UNH	£221.16	£380.64	72.11%	£120,477.48**
Mar '25	Lord Fink	Unitedhealth Group / NYQ:UNH	£518.20	£339.71	-34.44%	£45,889.04
Apr '25	Lord Grabiner	Unitedhealth Group / NYQ:UNH	£594.40	£339.71	-42.85%	£40,006.22
Oct '25	Lord Sterling of Plaistow	Unitedhealth Group / NYQ:UNH	£361.15	£339.71	-5.94%	£65,844.39
Feb '19	Lord Carter of Coles	Mettler Toledo / NYQ:MTD	£672.49	£1,434.88	113.37%	£149,357.76
May '19	Lord Sterling of Plaistow	Mettler Toledo / NYQ:MTD	£701.77	£1,481.07	111.05%	£147,733.44**
Sep '20	Lord Carter of Coles	Thermo Fisher Scientific / NYQ:TMO	£418.14	£580.45	38.82%	£97,172.00
Apr '22	Lord Grabiner	Thermo Fisher Scientific / NYQ:TMO	£570.94	£438.15	-23.26%	£53,719.30**
May '18	Lord Green of Hurstpierpoint	Thermo Fisher Scientific / NYQ:TMO	£215.97	£423.55	96.12%	£137,280.64**
Nov '23	Lord Mance	Thermo Fisher Scientific / NYQ:TMO	£459.24	£580.45	26.39%	£88,475.53
Aug '20	Lord Sterling of Plaistow	Thermo Fisher Scientific / NYQ:TMO	£416.17	£403.13	-3.13%	£67,806.66**
Jan '25	Lord Sassoon	Thermo Fisher Scientific / NYQ:TMO	£583.64	£580.45	-0.55%	£69,617.40
Aug '25	Lord Green of Hurstpierpoint	Thermo Fisher Scientific / NYQ:TMO	£463.04	£580.45	25.36%	£87,749.44
Aug '25	Lord Sterling of Plaistow	Thermo Fisher Scientific / NYQ:TMO	£477.41	£580.45	21.58%	£85,108.19
Sep '21	Lord Darzi of Denham	Oxford Nanopore / LSE:ONT.L	£612.60	£131.90	-78.47%	£15,071.82
Apr '22	Lord Spencer of Alresford	Oxford Nanopore / LSE:ONT.L	£320.00	£131.90	-58.78%	£28,853.12
Apr '21	Baroness Deech	Novo Nordisk As / NYQ:NVO	£36.35	£47.57	30.87%	£91,606.61
Apr '24	Lord Grabiner	Novo Nordisk As / NYQ:NVO	£127.46	£64.73	-49.22%	£35,549.19**
Nov '23	Lord Mance	Novo Nordisk As / NYQ:NVO	£101.69	£47.57	-53.22%	£32,745.60
May '22	Lord Reay	Novo Nordisk As / NYQ:NVO	£56.40	£140.80	149.67%	£174,767.27**
Nov '21	Lord Sherbourne of Didsbury	Novo Nordisk As / NYQ:NVO	£56.71	£70.73	24.73%	£87,313.29**
Apr '24	Lord Willoughby de Broke	Novo Nordisk As / NYQ:NVO	£122.75	£47.57	-61.25%	£27,127.49
May '24	Lord Londesborough	Novo Nordisk As / NYQ:NVO	£134.66	£47.57	-64.67%	£24,728.20
Apr '21	Baroness Deech	Zoetis / NYQ:ZTS	£168.10	£122.57	-27.09%	£51,040.45
Mar '25	Lord Fink	Zoetis / NYQ:ZTS	£162.82	£122.57	-24.72%	£52,695.61
Apr '21	Baroness Deech	Novartis / NYQ:NVS	£88.38	£133.72	51.30%	£105,910.84
Apr '17	Lord Donoughue	Novartis / NYQ:NVS	£66.05	£133.72	102.46%	£141,720.35
May '11	Lord Glendonbrook	Novartis / NYQ:NVS	£54.04	£133.72	147.44%	£173,208.53
Apr '23	Lord Grabiner	Novartis / NYQ:NVS	£95.80	£107.52	12.23%	£78,563.67**
Oct '19	Lord Farmer	Centene / NYQ:CNC	£44.09	£72.71	64.91%	£115,438.87**
May '23	Lord Fink	Healthcare Group / LSE:SPI.L	£227.50	£185.80	-18.33%	£57,169.23
Jan '24	Lord Fink	Roche / EBS:ROG.SW	£251.85	£313.80	24.60%	£87,218.58
Apr '21	Lord Grabiner	Roche / EBS:ROG.SW	£309.65	£313.80	1.34%	£70,938.15
Apr '17	Lord Leigh of Hurley	Roche / EBS:ROG.SW	£255.80	£313.80	22.67%	£85,871.77
Aug '20	Lord Reay	Roche / EBS:ROG.SW	£315.05	£249.80	-20.71%	£55,502.30**
Feb '25	Lord Green of Hurstpierpoint	Roche / EBS:ROG.SW	£285.70	£272.40	-4.66%	£66,741.33**
Mar '25	Lord Fink	Roche / EBS:ROG.SW	£303.00	£313.80	3.56%	£72,495.05
Nov '25	Lord Green of Hurstpierpoint	Roche / EBS:ROG.SW	£309.00	£313.80	1.55%	£71,087.38
May '11	Lord Glendonbrook	Abbott Laboratories / NYQ:ABT	£25.27	£125.29	395.88%	£347,114.98
May '23	Lord Londesborough	Abbott Laboratories / NYQ:ABT	£108.82	£125.29	15.14%	£80,594.56
Jan '13	Lord Sassoon	Abbott Laboratories / NYQ:ABT	£32.90	£125.29	280.82%	£266,574.45
May '11	Lord Glendonbrook	Mesoblast / NMS:MESO	£101.20	£16.93	-83.27%	£11,710.47
May '11	Lord Glendonbrook	Pfizer / NYQ:PFE	£19.54	£25.57	30.83%	£91,580.32
Feb '16	Lord Lloyd-Webber	Pfizer / NYQ:PFE	£29.02	£25.57	-11.90%	£61,672.27
May '11	Lord Glendonbrook	Smith & Nephew / NYQ:SNN	£22.61	£32.96	45.81%	£102,065.72
Apr '10	Baroness Noakes	Smith & Nephew / NYQ:SNN	£20.98	£32.96	57.10%	£109,969.34
Jan '13	Lord Glendonbrook	Waters / NYQ:WAT	£87.09	£397.62	356.56%	£319,593.53
Oct '13	Lord Glendonbrook	Stryker / NYQ:SYK	£69.42	£365.95	427.15%	£369,007.51
Nov '23	Lord Mance	Stryker / NYQ:SYK	£275.00	£365.95	33.07%	£93,150.91
Mar '14	Lord Glendonbrook	Bb Biotech / EBS:BION.SW	£33.36	£27.20	-18.47%	£57,074.34**
Jun '16	Lord Lloyd-Webber	Bb Biotech / EBS:BION.SW	£47.80	£45.45	-4.92%	£66,558.58
Mar '17	Lord Lloyd-Webber	Bb Biotech / EBS:BION.SW	£54.95	£45.45	-17.29%	£57,898.09
Oct '20	Lord Glendonbrook	Bds / NGM:BDSX	£12.81	£8.14	-36.46%	£44,480.88
May '15	Lord Glendonbrook	Medtronic / NYQ:MDT	£78.41	£86.77	10.66%	£77,463.33**
Jan '18	Lord Glendonbrook	Cvs Health / NYQ:CVS	£79.44	£75.00	-5.59%	£66,087.61
Feb '13	Lord Nash	Cvs Health / NYQ:CVS	£52.66	£77.90	47.93%	£103,551.08**
Jul '18	Lord Glendonbrook	Bayer / GER:BAYN.DE	£95.26	£34.25	-64.05%	£25,167.96
Jun '19	Lord Glendonbrook	Alcon / NYQ:ALC	£59.11	£80.92	36.90%	£95,828.11**
Dec '19	Lord Glendonbrook	Align Technology / NMS:ALGN	£273.75	£155.00	-43.38%	£39,634.70
May '24	Lord Goldsmith	Abbvie / NYQ:ABBV	£160.81	£230.24	43.18%	£100,222.63
Apr '21	Lord Grabiner	Boston Scientific / NYQ:BSX	£39.32	£93.67	138.22%	£166,757.37**
Apr '22	Lord Grabiner	Intuitive Surgical / NMS:ISRG	£277.85	£569.71	105.04%	£143,529.60
Jan '22	Lord Green of Hurstpierpoint	Intuitive Surgical / NMS:ISRG	£284.18	£529.42	86.30%	£130,408.19**
Nov '21	Lord Sherbourne of Didsbury	Intuitive Surgical / NMS:ISRG	£350.79	£569.71	62.41%	£113,685.40
Oct '25	Lord Carter of Coles	Intuitive Surgical / NMS:ISRG	£551.30	£569.71	3.34%	£72,337.57
Oct '15	Lord Hayward	Sage / NGM:SAGE	£46.11	£8.68	-81.18%	£13,177.19
Dec '22	Lord Hintze	Atai Life Sciences / NGM:ATAI	£3.48	£4.06	16.67%	£81,666.67
Dec '22	Lord Hintze	Affimed / NGM:AFMD	£21.20	£0.18	-99.14%	£599.29
Mar '11	Lord Hollick	HCA / NYQ:HCA	£31.02	£486.77	1,469.21%	£1,098,449.36
Nov '17	Lord Howard of Rising	Ekf Diagnostics / LSE:EKF.L	£25.01	£24.00	-4.04%	£67,172.59
Apr '22	Lord Hylton	Genus / LSE:GNS.L	£2,678.00	£2,590.00	-3.29%	£67,699.78
Jan '24	Lord Kakkar	Cyte / NMS:CTKB	£8.31	£3.71	-55.35%	£31,251.50**
Apr '10	Lord Lloyd-Webber	Idexx Labs / NMS:IDXX	£29.96	£725.93	2,323.00%	£1,696,098.17
Aug '16	Lord Lloyd-Webber	Eli Lilly / NYQ:LLY	£80.55	£67.15	-16.64%	£58,355.06**
Apr '24	Lord Mendoza	Eli Lilly / NYQ:LLY	£731.33	£1,033.56	41.33%	£98,928.26
Mar '17	Lord Lloyd-Webber	Hikma Pharmaceuticals / LSE:HIK.L	£2,026.00	£1,580.00	-22.01%	£54,590.33
Sep '21	Lord Londesborough	Definitive Healthcare / NMS:DH	£43.29	£2.59	-94.02%	£4,188.03
Jul '21	Lord Londesborough	Goodrx / NMS:GDRX	£32.52	£4.79	-85.27%	£10,310.58**
Nov '23	Lord Mance	Eli Lilly Co / VIE:LLYC.VI	£557.00	£892.10	60.16%	£112,113.10
Mar '24	Lord Moynihan of Chelsea	Candel Therapeutics / NGM:CADL	£1.40	£5.02	258.57%	£251,000.00
Mar '24	Lord Moynihan of Chelsea	Journey Medical / NCM:DERM	£3.74	£7.25	93.85%	£135,695.19**
Mar '24	Lord Moynihan of Chelsea	Evotec / NMS:EVO	£7.13	£3.19	-55.26%	£31,318.37
Mar '24	Lord Moynihan of Chelsea	Fortress Biotech / NCM:FBIO	£1.92	£2.69	40.10%	£98,072.92
Mar '24	Lord Moynihan of Chelsea	Mustang Bio / NCM:MBIO	£1.04	£1.19	14.42%	£80,096.16
Mar '24	Lord Moynihan of Chelsea	Tg Therapeutics / NCM:TGTX	£15.05	£31.61	110.03%	£147,023.26
Mar '24	Lord Moynihan of Chelsea	Adaptimmune / NMS:ADAP	£1.47	£0.04	-97.12%	£2,016.19
Mar '24	Lord Moynihan of Chelsea	Avenue Therapeutics / NCM:ATXI	£12.00	£0.76	-93.66%	£4,436.25
Apr '19	Lord Nash	Eq / NCM:EQ	£8.20	£0.69	-91.59%	£5,890.24**
Aug '23	Lord Nash	Relay / NGM:RLAY	£10.62	£7.83	-26.27%	£51,610.17
Sep '23	Lord Nash	Abingdon / LSE:ABDX.L	£11.25	£6.75	-40.00%	£42,000.00
Mar '24	Lord Petitgas	Royalty Pharma / NMS:RPRX	£30.08	£39.60	31.65%	£92,154.25
Mar '24	Lord Petitgas	Moderna / NMS:MRNA	£111.98	£25.18	-77.51%	£15,740.31
May '23	Lord Reay	Sanofi / NMS:SNY	£55.11	£47.22	-14.32%	£59,978.23**
May '22	Lord Saatchi	Walgreen / NMS:WBA	£43.85	£11.98	-72.68%	£19,124.29
Jul '23	Lord Sassoon	Haleon / LSE:HLN.L	£336.10	£361.10	7.44%	£75,206.78
Mar '23	Baroness Shields	Benevolentai / AMS:BAI.AS	£2.46	£0.09	-96.14%	£2,703.25**
Jan '21	Lord Spencer of Alresford	Immupharma / LSE:IMM.L	£12.65	£6.14	-51.46%	£33,976.28
May '23	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£180.80	£204.10	12.89%	£79,023.12**
Jun '24	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£208.20	£197.20	-5.28%	£66,301.63**
Aug '24	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£207.50	£308.80	48.82%	£104,173.49
Mar '25	Lord Fink	Essilorluxottica / PAR:EL.PA	£273.20	£308.80	13.03%	£79,121.52
Jun '22	Lord Stevens of Ludgate	Verici Dx / LSE:VRCI.L	£26.00	£0.75	-97.12%	£2,019.23
May '23	Lord Stevens of Ludgate	Avacta Group / LSE:AVCT.L	£112.00	£78.50	-29.91%	£49,062.50
Jul '25	Lord Fink	Avacta Group / LSE:AVCT.L	£51.50	£78.50	52.43%	£106,699.03
Jun '22	Lord Sugar	Acl / NMS:ACLX	£17.47	£72.94	317.52%	£292,261.05
May '22	Lord Triesman	Blue / NMS:BLUE	£3.39	£4.97	46.61%	£102,625.36
May '20	Lord Wolfson of Aspley Guise	Adc Therapeutics / NYQ:ADCT	£30.00	£3.95	-86.83%	£9,216.67
Nov '24	Lord Moynihan of Chelsea	Sab Biotherapeutics / NCM:SABS	£3.95	£3.70	-6.33%	£65,569.62

* Minimum Potential Value based on £70,000.00 invested at time of declaration.

** Interest ceased/exited on filed date.